GVBL
GENOMIC VALLEY BIOTECH LIMITEDHealthcare
LTP
30.1
CHG · %
+1.35 (+4.70%)
VOL · TODAY
500
PREV CLOSE
28.75
Today's range30.1 · 30.15
30.1
52-week range27.15 · 108.15
30.1
Loading candles…
Genomic Valley Biotech Ltd, incorporated in 2001, operates in the life sciences, biotechnology, horticulture, agriculture, and genomics industries primarily in India. The company engages in the production and service provision of horticultural and agricultural products, including high-tech cultivation and agricultural consultancy. It has expanded its focus to the genomics sector, offering services related to human, plant, and microbial genomics. Key areas include Next-Generation Sequencing (NGS) and molecular diagnostics. Additionally, Genomic Valley Biotech integrates artificial intelligence with biological data to support personalized healthcare and sustainable agriculture. The company does not have publicly disclosed founders, key management, subsidiaries, notable projects, or stock exchange listings.
GVBL is not part of any active scan today.
This page is a live market overview for GENOMIC VALLEY BIOTECH LIMITED (GVBL) on the BSE. As a listed security, GENOMIC VALLEY BIOTECH LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GVBL before placing trades on tick2trade.
As of the latest feed, GVBL last traded at ₹30.1 on BSE, up ₹1.35 (4.70%) from the previous close of ₹28.75. Today's session range is ₹30.1 – ₹30.15, against a 52-week band of ₹27.15 – ₹108.15. Traded volume today stands at 500 shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for GVBL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GVBL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GENOMIC VALLEY BIOTECH LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GVBL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GVBL option chain page linked from this overview.
// similar in healthcare314 total